Evidence map›Paper›PMID 41596681›Full record

ArticleInternational journal of molecular sciences2026

A Novel Approach to Combating Antibiotic Resistance: A Chitosan-Based Nanocomposite with Green AgNPs and Gentamicin.

Mukil Madhusudanan, Priyanka Singh, Viney Ghai, Santosh Pandit, Roland Kádár, Ivan Mijakovic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mukil MadhusudananThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kogens Lyngby, Denmark.ORCID 0009-0003-9814-5426
Priyanka SinghThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kogens Lyngby, Denmark.ORCID 0000-0001-7654-5339
Viney GhaiDepartment of Industrial and Materials Science, Chalmers University of Technology, 41296 Göteborg, Sweden.ORCID 0000-0002-0530-5757
Santosh PanditSystems and Synthetic Biology Division, Department of Life Sciences, Chalmers University of Technology, 41296 Göteborg, Sweden.ORCID 0000-0002-8357-758X
Roland KádárDepartment of Industrial and Materials Science, Chalmers University of Technology, 41296 Göteborg, Sweden.ORCID 0000-0002-6255-4952
Ivan MijakovicThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kogens Lyngby, Denmark.ORCID 0000-0002-8860-6853

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the synthesis of silver nanoparticles (AgNPs) using

Indexed as

Anti-Bacterial AgentsChitosanDrug Resistance, MicrobialGentamicinsMetal NanoparticlesNanocompositesSilverEscherichia coliMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsPlant ExtractsPseudomonas aeruginosaStaphylococcus epidermidisAnti-Bacterial AgentsChitosanGentamicinsPlant ExtractsSilverantimicrobial resistancechitosan nanocompositegentamicingreen synthesissilver nanoparticles

Identifiers

PMID41596681
PMCPMC12842585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.